- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07894926
Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale (ABILHAND-KYCTR)
The purpose of this study is to perform the Turkish translation, cross-cultural adaptation, validity, and reliability of the ABILHAND-Kids Young CP scale. This methodological and cross-sectional study aims to provide a culturally adapted and psychometrically sound assessment tool to evaluate manual ability in children aged 2 to 7 years with cerebral palsy, based on parent or primary caregiver reports.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The cross-cultural adaptation process follows international guidelines, including forward-translation, synthesis, back-translation, an expert committee review, and a pilot test. Construct validity and reliability will be evaluated using standardized statistical methods.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Ayşe Gül Türkmenoğlu, BSc, PT
- Telefoonnummer: +90 537 555 69 11
- E-mail: aysegulturkmenoglu@ogr.iuc.edu.tr
Studie Locaties
-
-
Istanbul
-
Istanbul, Istanbul, Turkije (Türkiye)
- Werving
- Istanbul University-Cerrahpasa, Faculty of Health Sciences
-
Contact:
- Ayşe Gül Türkmenoğlu, BSc, PT
- Telefoonnummer: +905375556911
- E-mail: aysegulturkmenoglu@ogr.iuc.edu.tr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Parents or primary caregivers of children aged 2 to 7 years diagnosed with cerebral palsy, applying to Yıldız Special Education and Rehabilitation Center.
Beschrijving
Inclusion Criteria:
- Children aged 2 to 7 years
- Confirmed diagnosis of Cerebral Palsy by a specialist physician
- Parent or primary caregiver having Turkish reading and comprehension ability
- Written informed consent provided by the parent or legal guardian
Exclusion Criteria:
- Presence of additional neurological or orthopedic conditions independently affecting manual ability other than cerebral palsy
- History of upper limb surgical intervention in the last 6 months
- Severe cognitive or behavioral problems that prevent the administration of the scale
- Incomplete or improperly filled questionnaire forms
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: CROSS_SECTIONAL
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Parents of Children with Cerebral Palsy
Parents or primary caregivers of children aged 2 to 7 years diagnosed with cerebral palsy, participating in the Turkish cross-cultural adaptation and validation study of the ABILHAND-Kids Young CP scale. |
Administration of the Turkish version of the ABILHAND-Kids Young CP questionnaire to evaluate manual ability in children with cerebral palsy. No medical, therapeutic, or surgical intervention is applied. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Turkish Version of the ABILHAND-Kids Young CP Scale Score
Tijdsspanne: At baseline (Day 1) and at retest (Day 10)
|
Evaluates manual ability and perceived difficulty in daily activities requiring upper limb use in children aged 2 to 7 years with cerebral palsy, based on parent or primary caregiver reports. The scale consists of 17 items, each scored on a 3-point ordinal scale (0 = impossible, 1 = difficult, 2 = easy). The total raw score ranges from 0 to 34 (converted into a linear Rasch measure from 0 to 100). Higher scores indicate better manual ability (a better outcome). |
At baseline (Day 1) and at retest (Day 10)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Children's Hand Use Experience Questionnaire (CHEQ) Score
Tijdsspanne: At baseline (Day 1)
|
Evaluates children's bimanual use, functional performance and participation levels in daily life activities, and strategies for using the affected hand based on parent or primary caregiver reports to assess convergent validity. The questionnaire assesses 27 bimanual activities across three subscales (Grasp Efficacy, Time Taken, and Feeling Bothered) on a 4-point ordinal scale (1 to 4), converted into linear scaled scores ranging from 0 to 100 for each subscale. Higher scores indicate better hand-use experience, higher functional performance, and less perceived difficulty (a better outcome). |
At baseline (Day 1)
|
Andere uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Manual Ability Classification System (MACS)
Tijdsspanne: At baseline
|
At baseline
|
|
Mini-Manual Ability Classification System ( Mini-MACS)
Tijdsspanne: At baseline
|
At baseline
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Sezen Karabörklü Argut, Study Principal Investigator, Istanbul University-Cerrahpasa, Faculty of Health Sciences
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IstanbulUC
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .